University of Pittsburgh’s Rachel Hibbs Receives ASCIP Excellence Award Rachel M. Hibbs, DPT, NCS, ATP, received the Excellence Award from the Therapy Leadership Council at the Academy of Spinal Cord Injury Professionals (ASCIP) annual conference. The award is given to a member “who has demonstrated outstanding qualities of leadership in the clinical application of SCI/D…
Briefly: Hibbs Receives ASCIP Award; New Disney Film Stars Young Actress with CP
Briefly: Etac Announces R82 Discontinuations; CP Foundation Lists September Clinical Trials
Featuring Etac and the Cerebral Palsy Foundation.
Etac Announces R82 Discontinuations for January 2025 Etac has announced products it will be discontinuing as of Jan. 1, 2025. In a Sept. 20 bulletin, Etac said it will stop offering the Orca bathtub; the Penguin bathtub positioning system; the Cricket manual wheelchair; the stroller-style Stingray manual wheelchair; and the Scallop seating system. Etac will…
Briefly: Colin Farrell Launches a Foundation; CP Foundation Updates Research Study Opportunities
Featuring the Colin Farrell Foundation and the Cerebral Palsy Foundation.
Actor Colin Farrell Launches Foundation to Support Adults with Intellectual Disabilities Irish actor Colin Farrell has launched the Colin Farrell Foundation, “committed to transforming the lives of individuals and families living with intellectual disability through education, awareness, advocacy and innovative programs.” In an Aug. 7 announcement, the Oscar-nominated actor launched his foundation’s website, which noted…
New Drug Trial Seeking Participants with Dyskinetic Cerebral Palsy
The Kinect-DCP clinical research study is testing a drug called valbenazine.
A new drug trial is seeking pediatric and adult participants, age 6 to 70, who have dyskinetic cerebral palsy (DCP) — including chorea, athetosis, or dystonia — that causes involuntary movements that are difficult to control. The Kinect-DCP clinical research study “is testing a study drug, called valbenazine, to determine if it is safe to…
Briefly: Day 2 of ISS:VPS Is March 6; CP Foundation Announces March Trials
Featuring the International Seating Symposium and the Cerebral Palsy Foundation.
ISS:VPS Continues March 6 The second day of the International Seating Symposium’s Virtual Professional Summit (ISS:VPS) is Wed., March 6. The VPS provides two days of seating and wheeled mobility education, with CEUs available. The March 6 session can be viewed live, and will also be available to view on demand. The first day of…
Cerebral Palsy Foundation Seeking Drug Trial Candidates
Study is seeking people living with dyskinetic cerebral palsy.
The Cerebral Palsy Foundation (CPF) is seeking out people with certain types of cerebral palsy to take part in a new clinical drug trial. In a Feb. 1 announcement, CPF said the trial is aimed at people with dyskinetic cerebral palsy, which is marked by various types of involuntary movements. The types of movements targeted…